Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Waterloo

$24,060.00

Development of novel tools and strategies for vector-based process intensification

EF 2010-11

Résumé
Viruses are extraordinary biological entities containing genetic information that provide cells with instructions for virus replication. These instructions are generally given priority over other cellular functions, giving the virus control of the cell. Virus replication, however, does not occur naturally outside of a cell; therefore, viruses have evolved to efficiently enter cells and deliver their genetic material. These characteristics make a virus a formidable foe when trying to combat viral diseases. Viruses, however, can also be used as an ally. They can be used to ""prime"" the immune system and act as a vaccine, or through genetic manipulation, can be ""engineered"" to direct cells to produce a desired product. Baculovirus, a virus that only replicates in insects, can be genetically engineered to direct insect cells in culture to produce virus-like particles (viruses devoid of genetic information) that are highly sought as vaccines. Challenge. Current world-wide cell culture capacity is not sufficient to meet the needs of a sudden viral outbreak, making the response to such an outbreak impossible. There is therefore a need to develop strategies for process intensification using a flexible production platform. The baculovirus expression platform allows both the flexibility and scale-up potential needed; however, at high densities, the use of large amounts of virus and drops in specific production limit the full potential of this system. To address these concerns, novel strategies and tools are needed. Novel infection strategies require an in-depth understanding of the system to be able to relate viral genome replication and transcription to protein expression. The driving hypothesis is that protein expression is limited at high densities by both viral genome replication and transcription. Novel tools are also needed to provide a better description of the cell's state before and after infection. High throughput phenotype microarray technology and other ""fingerprinting"" techniques will be used to characterize the cells and media to optimize the productions at high cell densities. This research will help position Canada as a leader in the manufacturing of vaccines based on virus-like particles and will train highly qualified personnel able to strengthen Canada's bio-pharmaceutical industry.
Programme
Discovery Grants Program - Individual
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
355513-2008
Name nom
Aucoin, Marc
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
24060
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
3
Nb partie
4
Application title
Development of novel tools and strategies for vector-based process intensification
Keyword
NSERC
Application summary
Viruses are extraordinary biological entities containing genetic information that provide cells with instructions for virus replication. These instructions are generally given priority over other cellular functions, giving the virus control of the cell. Virus replication, however, does not occur naturally outside of a cell; therefore, viruses have evolved to efficiently enter cells and deliver their genetic material. These characteristics make a virus a formidable foe when trying to combat viral diseases. Viruses, however, can also be used as an ally. They can be used to ""prime"" the immune system and act as a vaccine, or through genetic manipulation, can be ""engineered"" to direct cells to produce a desired product. Baculovirus, a virus that only replicates in insects, can be genetically engineered to direct insect cells in culture to produce virus-like particles (viruses devoid of genetic information) that are highly sought as vaccines. Challenge. Current world-wide cell culture capacity is not sufficient to meet the needs of a sudden viral outbreak, making the response to such an outbreak impossible. There is therefore a need to develop strategies for process intensification using a flexible production platform. The baculovirus expression platform allows both the flexibility and scale-up potential needed; however, at high densities, the use of large amounts of virus and drops in specific production limit the full potential of this system. To address these concerns, novel strategies and tools are needed. Novel infection strategies require an in-depth understanding of the system to be able to relate viral genome replication and transcription to protein expression. The driving hypothesis is that protein expression is limited at high densities by both viral genome replication and transcription. Novel tools are also needed to provide a better description of the cell's state before and after infection. High throughput phenotype microarray technology and other ""fingerprinting"" techniques will be used to characterize the cells and media to optimize the productions at high cell densities. This research will help position Canada as a leader in the manufacturing of vaccines based on virus-like particles and will train highly qualified personnel able to strengthen Canada's bio-pharmaceutical industry.